Related Experiment Videos
[Clinical observations with clarithromycin in pediatrics]
T Sekiguchi1, T Okamoto, K Ohara
1Department of Pediatrics, Takamatsu Red Cross Hospital.
Insights
Clarithromycin, an oral antibiotic, showed excellent results in treating 25 children with various bacterial infections. This study found TE-031 effective and safe for pediatric bacterial infections.
Area of Science:
- Pediatric infectious diseases
- Antibiotic research and development
- Pharmacology
Context:
- Acute bacterial infections in children pose significant health challenges.
- Effective and safe antibiotic options are crucial for pediatric care.
- Clarithromycin (TE-031) is an investigational antibiotic for bacterial infections.
Purpose:
- To evaluate the clinical efficacy and safety of clarithromycin (TE-031) in pediatric patients with acute bacterial infections.
- To assess bacterial eradication rates following clarithromycin treatment.
- To identify potential side effects associated with TE-031 administration in children.
Summary:
- Twenty-five children with acute bacterial infections (bronchitis, pneumonia, Mycoplasma pneumonia, pertussis, Campylobacter enteritis) received oral clarithromycin (TE-031).
- Clinical responses were good to excellent in 22 patients, with successful bacterial eradication observed in all 10 strains tested.
- No adverse side effects were reported during the study period.
Impact:
- Clarithromycin (TE-031) demonstrates significant potential as a safe and effective antibiotic for treating a range of bacterial infections in pediatric populations.
- The findings support the use of TE-031 in pediatric infectious disease management.
- Further research may confirm TE-031's role in the pediatric antibiotic armamentarium.
Abstract:
Clarithromycin (TE-031, A-56268) was given orally to 25 children with acute bacterial infections including 5 with bronchitis, 8 with pneumonia, 4 with Mycoplasma pneumonia, 2 with pertussis and 6 with Campylobacter enteritis. Good to excellent clinical responses were obtained in 22 patients with bacterial eradication of all 10 strains. No side effect was observed. From the above clinical results, it appears that TE-031 is a useful antibiotic for the treatment of pediatrics with various bacterial infections.